{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:04:44Z","timestamp":1767110684154,"version":"3.48.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    This study investigated whether preemptive\n                    <jats:italic toggle=\"yes\">NUDT15<\/jats:italic>\n                    genotyping can reduce episodes of febrile neutropenia during the continuation phase of acute lymphoblastic leukemia (ALL) treatment. This retrospective cohort study enrolled 243 children with ALL who were treated according to the Taiwan Pediatric Oncology Group protocol at the National Taiwan University Hospital. The patients were divided into those who underwent preemptive\n                    <jats:italic toggle=\"yes\">NUDT15<\/jats:italic>\n                    genotyping (n=30) and historical controls (n=213). Febrile neutropenia episodes were compared between groups stratified by risk classification (standard risk [SR], high-risk [HR], very high-risk [VHR] groups). Multivariate analysis was performed, and the dosage was adjusted for age, sex, and mercaptopurine. Preemptive genotyping did not significantly reduce febrile neutropenia episodes in the SR, HR, and VHR patient groups\u2014although a general trend toward reduction was observed. VHR patients with compound heterozygous\n                    <jats:italic toggle=\"yes\">NUDT15<\/jats:italic>\n                    polymorphisms had a significantly higher risk (risk ratio: 5.6,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.001). Younger age at diagnosis was determined to be a predictor of febrile neutropenia. Preemptive\n                    <jats:italic toggle=\"yes\">NUDT15<\/jats:italic>\n                    genotyping did not significantly reduce febrile neutropenia episodes in our cohort of pediatric patients with ALL, although it allowed a potential reduction in HR patients. Clinicians should consider preemptive testing, particularly in HR and VHR patient groups, to optimize ALL treatments and reduce adverse events.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003154","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:00:13Z","timestamp":1765288813000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Preemptive NUDT15 Genotyping and Its Impact on Febrile Neutropenia in Pediatric Patients With Acute Lymphoblastic Leukemia in Taiwan"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-4501","authenticated-orcid":false,"given":"Chiao-Yu","family":"Cheng","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-6670","authenticated-orcid":false,"given":"Der-Shiun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, College of Medicine, National Defense Medical University"},{"name":"Department of Pediatrics, Tri-Service General Hospital"},{"name":"PhD Program, Graduate Institute of Clinical Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsiang","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Statistical Science Academia Sinica, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiann-Tarng","family":"Jou","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Statistical Science Academia Sinica, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Hsin","family":"Lin","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Yao","family":"Lu","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Hao","family":"Chang","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Chou","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jui","family":"Du","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ling","family":"Ni","sequence":"additional","affiliation":[{"name":"Laboratory Medicine, National Taiwan University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Tsamn","family":"Lin","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Laboratory Medicine, National Taiwan University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wha","family":"Lin","sequence":"additional","affiliation":[{"name":"Departments of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Statistical Science Academia Sinica, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Laboratory Medicine, National Taiwan University Hospital"},{"name":"Laboratory Medicine, College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"R1-20251230","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision medicine in acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2020","journal-title":"Front Med"},{"key":"R3-20251230","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude total therapy study 16","volume":"37","author":"Jeha","year":"2019","journal-title":"J Clin Oncol"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.beha.2017.07.007","article-title":"Pharmacogenomics in acute lymphoblastic leukemia","volume":"30","author":"Lee","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J Clin Oncol"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41375-022-01591-4","article-title":"Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations","volume":"36","author":"Toksvang","year":"2022","journal-title":"Leukemia"},{"key":"R8-20251230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/FPC.0000000000000453","article-title":"Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia","volume":"32","author":"Moriyama","year":"2022","journal-title":"Pharmacogenet Genomics"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41390-020-0868-8","article-title":"Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants","volume":"89","author":"Wang","year":"2021","journal-title":"Pediatr Res"},{"key":"R10-20251230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/tpj.2015.75","article-title":"NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia","volume":"16","author":"Liang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"R11-20251230","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R12-20251230","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood-2017-05-782383","article-title":"Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry","volume":"130","author":"Moriyama","year":"2017","journal-title":"Blood"},{"key":"R14-20251230","first-page":"1053","article-title":"Association of NUDT15 gene polymorphism with adverse reaction, treatment efficacy, and dose of 6-mercaptopurine in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"109","author":"Du","year":"2023","journal-title":"Haematologica"},{"key":"R15-20251230","first-page":"4764","article-title":"A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols","volume":"12","author":"Chang","year":"2022","journal-title":"Am J Cancer Res"},{"key":"R16-20251230","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1002\/cncr.31758","article-title":"Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study","volume":"124","author":"Yeh","year":"2018","journal-title":"Cancer"},{"key":"R17-20251230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.34606","article-title":"Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia","volume":"129","author":"Yu","year":"2023","journal-title":"Cancer"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"155287","DOI":"10.1016\/j.prp.2024.155287","article-title":"Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia","volume":"256","author":"Yu","year":"2024","journal-title":"Pathol Res Pract"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41598-023-27720-2","article-title":"Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic leukemia","volume":"13","author":"Yu","year":"2023","journal-title":"Sci Rep"},{"key":"R20-20251230","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"R21-20251230","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/cpt.1268","article-title":"Pharmacogene variation consortium gene introduction: NUDT15","volume":"105","author":"Yang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"R22-20251230","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/bjh.19338","article-title":"Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: combining IKZF1(plus) and Day 15 MRD positivity","volume":"204","author":"Liu","year":"2024","journal-title":"Br J Haematol"},{"key":"R23-20251230","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fphar.2019.00916","article-title":"ITPA, TPMT, and NUDT15 genetic polymorphisms predict 6-mercaptopurine toxicity in Middle Eastern children with acute lymphoblastic leukemia","volume":"10","author":"Moradveisi","year":"2019","journal-title":"Front Pharmacol"},{"key":"R24-20251230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpeds.2019.09.024","article-title":"The role of TPMT, ITPA, and NUDT15 variants during mercaptopurine treatment of Swedish pediatric patients with acute lymphoblastic leukemia","volume":"216","author":"Wahlund","year":"2020","journal-title":"J Pediatr"},{"key":"R25-20251230","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","article-title":"Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus","volume":"91","author":"Relling","year":"1999","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:00:38Z","timestamp":1767110438000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003154","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"type":"print","value":"1077-4114"},{"type":"electronic","value":"1536-3678"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"2025-03-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}